Open Field 3 / About

About

An independent resource built for people who want careful context, clear limits, and language that does not overstate what evidence can say.

Hands held together in a quiet moment of consideration

Context before conclusions.

Open Field 3 exists because people looking at difficult health questions often encounter certainty before context. Soma Flint is an independent resource on ibogaine, noribogaine, neuroplasticity research, and cardiac safety. It distinguishes early findings, observational evidence, and established risks without overstating conclusions.

The main research resource is arranged to make that distinction visible: what a source reports, what it cannot establish, and where questions remain open. For a short explanation of commonly used evidence terms, the National Library of Medicine’s discussion of study design offers useful background on why methods matter.

Traceable, proportionate, plainspoken.

We organize material around the questions a reader needs to ask, rather than around a promised outcome. The resource draws from published literature, study registries, official material, and source documents where available. Research listings can be checked against the ClinicalTrials.gov study registry, while individual papers are considered alongside their design, scope, and stated limitations.

We aim to separate a finding from an interpretation and an interpretation from a decision. That approach informs the practical orientation of our research navigation services, which help readers locate information without turning it into medical or legal advice.

How we hold the work.

  • Scientific humilityWe mark uncertainty rather than smoothing it away.
  • Safety clarityWe make established risks visible without sensationalizing them.
  • Plain languageWe prefer understandable explanations over unnecessary jargon.
  • IndependenceWe describe sources and limits without presenting clinical endorsement.
  • Evidence contextWe attend to the kind of evidence, not only the conclusion attached to it.

A map, not a directive.

This resource covers the questions surrounding ibogaine research in an organized, general-reference format. It places basic orientation, safety context, study-reading tools, and topic pathways in separate areas so that readers can identify the kind of information they are looking at.

For example, pages about ibogaine and depression, treatment questions in Seattle, and clinic-related questions in Mexico are offered as distinct starting points, not endorsements or treatment recommendations.

Open landscape suggesting room for measured inquiry and reflection

For people seeking careful context, not a shortcut.

Who this is for

Open Field 3 is for people seeking accessible context on research, potential mechanisms, and established safety concerns. It is designed for readers who want a clearer way to approach sources and a more useful vocabulary for assessing claims.

Information has limits. We name them.

Open Field 3 is independent of clinics and treatment providers. It does not diagnose, recommend treatment, assess eligibility, or provide legal advice. Readers considering health decisions should seek appropriately qualified professional support and consult current official information, including the U.S. Food and Drug Administration’s drug information where relevant.

Topic pages on ibogaine for PTSD treatment, ibogaine detox centers, and a Tijuana ibogaine clinic are framed to help readers recognize the boundaries between information, marketing, and professional care.

Start with the evidence, keep the questions open.

Research Primer